Study
Myo-inositol and Selenium Improve Thyroid Function in Hashimoto's Patients
Taking myo-inositol with selenium helped improve thyroid hormone levels in patients with mild hypothyroidism due to Hashimoto's disease.
Summary
In plain language
In a study involving patients with Hashimoto's thyroiditis, researchers found that supplementing with myo-inositol and selenium led to better thyroid function. The study included 168 individuals with mild thyroid issues and divided them into two groups. One group received the combined supplements, while the other received only selenium. After six months, those taking both myo-inositol and selenium showed significant improvements in their thyroid hormone levels and reported a better quality of life. This suggests that these supplements could be beneficial for those with Hashimoto's thyroiditis experiencing mild hypothyroidism. It's always a good idea to discuss new supplements with your doctor.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study explored the effects of myo-inositol and selenium on thyroid function in people with Hashimoto's thyroiditis experiencing mild hypothyroidism.
The research involved 168 participants who were split into two groups: one took myo-inositol and selenium, the other took selenium alone.
After six months, the group taking both supplements showed lower levels of certain thyroid antibodies and higher thyroid hormone levels.
While the results are promising, further studies could help confirm these findings, and individuals should consult their healthcare provider before starting new supplements.
These findings suggest that adding myo-inositol and selenium to your routine might support thyroid health, especially for those with Hashimoto's. Always talk to your doctor before trying new supplements.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Myo-inositol and Selenium Improve Thyroid Function in Hashimoto's Patients
Published May 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored May 10, 2026 using rubric v9_2026-04-08.
Assessment
The study is a randomized controlled trial examining the effects of myo-inositol and selenium on thyroid function in Hashimoto's patients. While it has a basic design and some statistical analysis, it lacks detailed methodological transparency and replication. The study's relevance to seniors is limited as the age of participants is not specified.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 6.7/10 | |
| Bias control | 5.0/10 | |
| Statistical methods | 5.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study could benefit from more detailed reporting on randomization, blinding, and statistical power. The lack of replication and specific focus on seniors limits its applicability to the senior population.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Supplements
Supplements help fill nutritional gaps and support healthy aging. For seniors, vitamins, minerals, and omega-3s can enhance bone strength, heart health, energy, and immune function when used safely under professional guidance.
Selenium
Selenium supports thyroid hormone production, antioxidant defense, and immune function.
Inositol (Myo-inositol)
Inositol supports mood stability, nerve signaling, and metabolic health, aiding emotional balance and insulin sensitivity.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.